Interview: AstraZeneca’s Pangalos On Landmark DAPA-HF Results

 
• By Eleanor Malone
  
Menelas (Mene) Pangalos
Mene Pangalos, AstraZeneca EVP Biopharmaceuticals R&D • Source: AstraZeneca

More from Cardiovascular

More from Therapy Areas